Okla. Opioid Case 'Should End Here And Now,' J&J Says

Law360 (July 3, 2019, 7:27 PM EDT) -- Johnson & Johnson is savaging Oklahoma's performance during a first-of-its-kind trial blaming the pharmaceutical giant for the opioid crisis, arguing that the state's case is breathtakingly weak and should be shut down.

In a 124-page motion on Wednesday, J&J and its Janssen Pharmaceuticals unit asserted that Oklahoma clearly failed during five weeks of testimony to show that the companies caused an addiction epidemic. According to the motion, Oklahoma Judge Thad Balkman should find in the companies' favor on the state's public nuisance claim — its sole theory of liability — and thereby reject the state's effort to extract $17 billion over...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS